Recent Finacing
Recent Raise
Altermune Technologies develops bifunctional linker therapeutics that use aptamer-based pathogen binding and epitope presentation to retarget patients' endogenous antibodies, with university and industry research collaborations and in vivo proof-of-concept.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor